Modern Pathways in Vascular Care

By Peter A. Schneider, MD

How Have PE Algorithms Changed Since the Advent of MT and PERTs?

The introduction of mechanical thrombectomy and PERTs has ushered in a new era of pulmonary embolism management, involving standardized, team-based, clinical decision-making pathways; expanded therapeutic options; more risk-stratified and individualized algorithms; and more.

With Kenneth Rosenfield, MD, MHCDS; Krunal H. Patel, MD; Parth Rali, MD; and Patrick Muck, MD

Effects of the Carotid Artery Stenting NCD on Current Decision-Making for Carotid Disease

Impact of the NCD on referrals and volumes of transfemoral carotid artery stenting, the multidisciplinary approach to evaluation and treatment, considering patient factors and patient preference, device selection, and approaches to concomitant stroke and carotid disease.

With Meghan Dermody, MD, and Adnan Siddiqui, MD, PhD

What if the ATTRACT Trial Had Been Positive?

Reflections on what is lost and gained when a well-designed trial produces unexpected results.

By Suresh Vedantham, MD

Exploring the Effects of the Paclitaxel Pause

Dr. Secemsky discusses patient perspectives, recent study findings, and the evolving peripheral market.

With Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

How Has Retrograde Access Changed Your CLTI Practice and Algorithms?

Retrograde access is an integral and routine component of CLTI revascularization strategies, offering improved success rates for complex occlusion patterns and crossing CTOs and an alternative when a traditional antegrade approach fails.

With John H. Rundback, MD, FAHA, FSVM, FSIR; Venita Chandra, MD; and S. Jay Mathews, MD, MS, FACC, FSCAI

Stroke Game Changers: Which Trials Have Most Affected Your Algorithms?

With Michael Chen, MD; Ameer Hassan, DO; and James Milburn, MD, MMM, FACR, FSNIS

Evolving Follow-Up Protocols After EVAR: Toward Precision Surveillance

The paradigm is shifting from uniform imaging schedules to risk-based, patient-specific follow-up.

By Behzad S. Farivar, MD, FACS, and Margaret C. Tracci, MD, JD

Acute GI Bleed Management: Lessons Learned at a High-Volume Academic Medical Center

Patient throughput and management of GI bleeds, from initial presentation through definitive management.

By Alborz Feizi, MD, PhD; Rahul Patel, MD; Kirema Garcia-Reyes, MD; and Aaron Fischman, MD

State of Dialysis Access and Current Challenges

Dr. Vandana Dua Niyyar discusses the current state of dialysis access and its challenges, essentials of a successful dialysis practice, device and therapy trends, the Transforming Dialysis Access Together initiative and its goals for education and training of fellows and dialysis access professionals, and ideals for the future of dialysis access.

With Vandana Dua Niyyar, MD, FASN, FNKF, FASDIN

Urgent-Start Peritoneal Dialysis: Patient Selection and Procedural Considerations

An interventional radiologist’s guide to placement of urgent peritoneal dialysis catheters, an efficient, cost-effective, minimally invasive alternative to traditional surgical placement.

By Ahmed K. Abdel-Aal, MD, PhD; Mohamed Shahin, MD, PhD, MBA; Shahroz K. Aziz, MD; Husameddin M. El Khudari, MD; and Ammar Almehmi, MD, MPH

Dialysis Access Maintenance in 2025: What Factors Drive Decisions?

Successful access management relies on durability, consideration of current and future access needs, timely access to care, and prioritization of the patients’ preferences and goals.

With Bart Dolmatch, MD, FSIR; Dheeraj K. Rajan, MD, FRCPC, FSIR, FACR; Dalia Zaky Dawoud, MD, MSc, FASDIN; and Theodore H. Yuo, MD, MSc, FACS, FSVS

An Interview With Pascal M. Jabbour, MD

Dr. Jabbour discusses the evolution of transradial access for neurointervention, his collaboration with Wills Eye Hospital on intra-arterial chemotherapy for pediatric patients with retinoblastoma, keys to a robust research practice, and the biggest challenges in stroke care today.